Treatment of epilepsy associated with primary and metastatic brain tumors
Open Access
- 29 October 2021
- journal article
- review article
- Published by IRBIS in Epilepsy and paroxysmal conditions
- Vol. 13 (3) , 286-304
Abstract
There is a number of unsolved issues in management of epilepsy associated with primary and metastatic brain tumors (BTs). In particular, no consensus approaches to treatment of patients with epilepsy associated with BTs have been proposed regarding use of current anti-epileptic drugs (AEDs). The review presents the relevant data on epidemiology, features of clinically manifested epilepsy at varying stages of BTs, aspects of drug-drug interaction between AEDs and anti-tumor agents, AED-related effects on cognitive functions as well as quality of life in patients with epilepsy associated with BTs. Levetiracetam and valproic acid comprise the first-line drugs for treating seizures in patients with BTs. It is unreasonable to use AEDs acting as hepatic microsomal enzyme inducers for therapy of epileptic seizures in BTs, because it may decrease efficacy of chemotherapy agents and glucocorticoids along with elevated rate of side effects. Perampanel acting as a selective noncompetitive AMPA receptor antagonist, may be one of the drugs of choice for the adjunctive therapy of epileptic seizures associated with BTs.Keywords
This publication has 75 references indexed in Scilit:
- Overexpression of Calcium-Permeable Glutamate Receptors in Glioblastoma Derived Brain Tumor Initiating CellsPLOS ONE, 2012
- Glutamate release by primary brain tumors induces epileptic activityNature Medicine, 2011
- Epidemiology of Metastatic Brain TumorsNeurosurgery Clinics of North America, 2011
- AMPA receptors promote perivascular glioma invasion via β1 integrin–dependent adhesion to the extracellular matrixNeuro-Oncology, 2009
- The course of neurocognitive functioning in high-grade glioma patients1Neuro-Oncology, 2007
- Seizure Prophylaxis in Patients With Brain Tumors: A Meta-analysisMayo Clinic Proceedings, 2004
- Anti‐tumor mechanisms of valproate: A novel role for an old drugMedicinal Research Reviews, 2002
- Current applications of health-related quality-of-life assessment in oncologySupportive Care in Cancer, 1997
- Cortical Tuber Count: A Biomarker Indicating Neurologic Severity of Tuberous Sclerosis ComplexJournal of Child Neurology, 1997
- A critical review of dimension-specific measures of health-related quality of life in cross-cultural researchQuality of Life Research, 1993